Role of tumor suppressor p53 in megakaryopoiesis and platelet function

Experimental Hematology

Volumn 40, Issue 2, 2012, Pages 131-142.e4

  Apostolidis, Pani A ^a,b   Woulfe, Donna S ^b   Chavez, Massiel ^b   Miller, William M ^a   Papoutsakis, Eleftherios T ^a,b  

^a Northwestern University   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; PADGEM PROTEIN; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLEEDING TIME; CELL CULTURE; CELL DIFFERENTIATION; CELL SIZE; CONTROLLED STUDY; DNA SYNTHESIS; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; HUMAN CELL; MALE; MEGAKARYOPOIESIS; MOUSE; NONHUMAN; PLASMA PROTEIN BINDING; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN SECRETION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

MURINAE; MUS;

EID: 84855610427     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2011.10.006     Document Type: Article

References (65)

1. Vousden K.H., Lane D.P. p53 in health and disease. Nat Rev Mol Cell Biol 2007, 8:275-283.
2. Dumble M., Moore L., Chambers S.M., et al. The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood 2007, 109:1736-1742.
3. Liu Y., Elf S.E., Miyata Y., et al. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 2009, 4:37-48.
4. TeKippe M., Harrison D.E., Chen J. Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice. Exp Hematol 2003, 31:521-527.
5. Liu Y., Elf S.E., Asai T., et al. The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior. Cell Cycle 2009, 8:3120-3124.
6. Chen C., Fuhrken P.G., Huang L.T., et al. A systems-biology analysis of isogenic megakaryocytic and granulocytic cultures identifies new molecular components of megakaryocytic apoptosis. BMC Genomics 2007, 8:384.
7. Fuhrken P.G., Apostolidis P.A., Lindsey S., Miller W.M., Papoutsakis E.T. Tumor suppressor protein p53 regulates megakaryocytic polyploidization and apoptosis. J Biol Chem 2008, 283:15589-15600.
8. Fuhrken P.G., Chen C., Apostolidis P.A., Wang M., Miller W.M., Papoutsakis E.T. Gene Ontology-driven transcriptional analysis of CD34+ cell-initiated megakaryocytic cultures identifies new transcriptional regulators of megakaryopoiesis. Physiol Genomics 2008, 33:159-169.
9. Fuhrken P.G., Chen C., Miller W.M., Papoutsakis E.T. Comparative, genome-scale transcriptional analysis of CHRF-288-11 and primary human megakaryocytic cell cultures provides novel insights into lineage-specific differentiation. Exp Hematol 2007, 35:476-489.
10. Giammona L.M., Panuganti S., Kemper J.M., et al. Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition. Exp Hematol 2009, 37. 1340-1352, e3.
11. Ritchie A., Braun S.E., He J., Broxmeyer H.E. Thrombopoietin-induced conformational change in p53 lies downstream of the p44/p42 mitogen activated protein kinase cascade in the human growth factor-dependent cell line M07e. Oncogene 1999, 18:1465-1477.
12. Ritchie A., Vadhan-Raj S., Broxmeyer H.E. Thrombopoietin suppresses apoptosis and behaves as a survival factor for the human growth factor-dependent cell line, M07e. Stem Cells 1996, 14:330-336.
13. Sigurjonsson O.E., Gudmundsson K.O., Haraldsdottir V., Rafnar T., Agnarsson B.A., Gudmundsson S. Flt3/Flk-2 ligand in combination with thrombopoietin decreases apoptosis in megakaryocyte development. Stem Cells Dev 2004, 13:183-191.
14. Wlodarski P., Wasik M., Ratajczak M.Z., et al. Role of p53 in hematopoietic recovery after cytotoxic treatment. Blood 1998, 91:2998-3006.
15. Horie K., Kubo K., Yonezawa M. p53 dependency of radio-adaptive responses in endogenous spleen colonies and peripheral blood-cell counts in C57BL mice. J Radiat Res (Tokyo) 2002, 43:353-360.
16. Jacks T., Remington L., Williams B.O., et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994, 4:1-7.
17. Barlow J.L., Drynan L.F., Hewett D.R., et al. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q-syndrome. Nat Med 2010, 16:59-66.
18. Pestina T.I., Cleveland J.L., Yang C., Zambetti G.P., Jackson C.W. Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis. Blood 2001, 98:2084-2090.
19. Eidelman O., Jozwik C., Huang W., et al. Gender dependence for a subset of the low-abundance signaling proteome in human platelets. Hum Genomics Proteomics 2010, 2010:164906.
20. Larson M.K., Watson S.P. Regulation of proplatelet formation and platelet release by integrin alpha IIb beta3. Blood 2006, 108:1509-1514.
21. Arnold J.T., Daw N.C., Stenberg P.E., Jayawardene D., Srivastava D.K., Jackson C.W. A single injection of pegylated murine megakaryocyte growth and development factor (MGDF) into mice is sufficient to produce a profound stimulation of megakaryocyte frequency, size, and ploidization. Blood 1997, 89:823-833.
22. Hitchcock I.S., Fox N.E., Prevost N., Sear K., Shattil S.J., Kaushansky K. Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout. Blood 2008, 111:596-604.
23. Lindsey S., Papoutsakis E.T. The aryl hydrocarbon receptor (AHR) transcription factor regulates megakaryocytic polyploidization. Br J Haematol 2011, 152:469-484.
24. Kostyak J.C., Naik U.P. Calcium- and integrin-binding protein 1 regulates endomitosis and its interaction with Polo-like kinase 3 is enhanced in endomitotic Dami cells. PLoS One 2011, 6:e14513.
25. Giammona L.M., Fuhrken P.G., Papoutsakis E.T., Miller W.M. Nicotinamide (vitamin B3) increases the polyploidisation and proplatelet formation of cultured primary human megakaryocytes. Br J Haematol 2006, 135:554-566.
26. Gilles L., Guieze R., Bluteau D., et al. P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1. Blood 2008, 111:4081-4091.
27. Tucker K.L., Sage T., Stevens J.M., et al. A dual role for integrin-linked kinase in platelets: regulating integrin function and alpha-granule secretion. Blood 2008, 112:4523-4531.
28. Prevost N., Woulfe D.S., Jiang H., et al. Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets. Proc Natl Acad Sci U S A 2005, 102:9820-9825.
29. Jiang F., Jia Y., Cohen I. Fibronectin- and protein kinase C-mediated activation of ERK/MAPK are essential for proplateletlike formation. Blood 2002, 99:3579-3584.
30. Yang H., Haddad H., Tomas C., Alsaker K., Papoutsakis E.T. A segmental nearest neighbor normalization and gene identification method gives superior results for DNA-array analysis. Proc Natl Acad Sci U S A 2003, 100:1122-1127.
31. Mercher T., Cornejo M.G., Sears C., et al. Notch signaling specifies megakaryocyte development from hematopoietic stem cells. Cell Stem Cell 2008, 3:314-326.
32. Chang Y., Bluteau D., Debili N., Vainchenker W. From hematopoietic stem cells to platelets. J Thromb Haemost 2007, 5(suppl 1):318-327.
33. Chen Z., Hu M., Shivdasani R.A. Expression analysis of primary mouse megakaryocyte differentiation and its application in identifying stage-specific molecular markers and a novel transcriptional target of NF-E2. Blood 2007, 109:1451-1459.
34. Saeed A.I., Sharov V., White J., et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34:374-378.
35. Muntean A.G., Pang L., Poncz M., Dowdy S.F., Blobel G.A., Crispino J.D. Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization. Blood 2007, 109:5199-5207.
36. Jirouskova M., Shet A.S., Johnson G.J. A guide to murine platelet structure, function, assays, and genetic alterations. J Thromb Haemost 2007, 5:661-669.
37. Nieswandt B., Schulte V., Bergmeier W. Flow-cytometric analysis of mouse platelet function. Methods Mol Biol 2004, 272:255-268.
38. Goodall A.H., Appleby J. Flow-cytometric analysis of platelet-membrane glycoprotein expression and platelet activation. Methods Mol Biol 2004, 272:225-253.
39. Shattil S.J. Signaling through platelet integrin alpha IIb beta 3: inside-out, outside-in, and sideways. Thromb Haemost 1999, 82:318-325.
40. Konopatskaya O., Gilio K., Harper M.T., et al. PKCalpha regulates platelet granule secretion and thrombus formation in mice. J Clin Invest 2009, 119:399-407.
41. Baccini V., Roy L., Vitrat N., et al. Role of p21(Cip1/Waf1) in cell-cycle exit of endomitotic megakaryocytes. Blood 2001, 98:3274-3282.
42. Mahdi T., Brizard A., Millet C., Dore P., Tanzer J., Kitzis A. Invitro p53 and/or Rb antisense oligonucleotide treatment in association with growth factors induces the proliferation of peripheral hematopoietic progenitors. J Cell Sci 1995, 108(Pt 3):1287-1293.
43. Luoh S.M., Stefanich E., Solar G., et al. Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin invivo. Mol Cell Biol 2000, 20:507-515.
44. Hu Z., Slayton W.B., Rimsza L.M., Bailey M., Sallmon H., Sola-Visner M.C. Differences between newborn and adult mice in their response to immune thrombocytopenia. Neonatology 2010, 98:100-108.
45. Wen Q., Leung C., Huang Z., et al. Survivin is not required for the endomitotic cell cycle of megakaryocytes. Blood 2009, 114:153-156.
46. McCrann D.J., Yezefski T., Nguyen H.G., et al. Survivin overexpression alone does not alter megakaryocyte ploidy nor interfere with erythroid/megakaryocytic lineage development in transgenic mice. Blood 2008, 111:4092-4095.
47. Mantel C., Braun S.E., Reid S., et al. p21(cip-1/waf-1) deficiency causes deformed nuclear architecture, centriole overduplication, polyploidy, and relaxed microtubule damage checkpoints in human hematopoietic cells. Blood 1999, 93:1390-1398.
48. Gurbuxani S., Xu Y., Keerthivasan G., Wickrema A., Crispino J.D. Differential requirements for survivin in hematopoietic cell development. Proc Natl Acad Sci U S A 2005, 102:11480-11485.
49. Yang D., Welm A., Bishop J.M. Cell division and cell survival in the absence of survivin. Proc Natl Acad Sci U S A 2004, 101:15100-15105.
50. Beltrami E., Plescia J., Wilkinson J.C., Duckett C.S., Altieri D.C. Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis. J Biol Chem 2004, 279:2077-2084.
51. Lordier L., Chang Y., Jalil A., et al. Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process. Blood 2010, 116:2345-2355. Epub 2010 Jun 14.
52. Wu Q., Xu F.L., Li Y., Prochownik E.V., Saunders W.S. The c-Myc target Glycoprotein1balpha links cytokinesis failure to oncogenic signal transduction pathways in cultured human cells. PLoS One 2010, 5:e10819.
53. Sachdeva M., Zhu S., Wu F., et al. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A 2009, 106:3207-3212.
54. Guo Y., Niu C., Breslin P., et al. c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Blood 2009, 114:2097-2106.
55. Tiedt R., Coers J., Ziegler S., et al. Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes. Blood 2009, 113:1768-1777.
56. Talos F., Moll U.M. Role of the p53 family in stabilizing the genome and preventing polyploidization. Adv Exp Med Biol 2010, 676:73-91.
57. Leysi-Derilou Y., Robert A., Duchesne C., Garnier A., Boyer L., Pineault N. Polyploid megakaryocytes can complete cytokinesis. Cell Cycle 2010, 9:2589-2599.
58. Zhao Y., Zhang Y., Wang S., Hua Z., Zhang J. The clock gene Per2 is required for normal platelet formation and function. Thromb Res 2011, 127:122-130.
59. Leon C., Eckly A., Hechler B., et al. Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion. Blood 2007, 110:3183-3191.
60. Sun H.Q., Yamamoto M., Mejillano M., Yin H.L. Gelsolin, a multifunctional actin regulatory protein. J Biol Chem 1999, 274:33179-33182.
61. Witke W., Sharpe A.H., Hartwig J.H., Azuma T., Stossel T.P., Kwiatkowski D.J. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell 1995, 81:41-51.
62. Huang C., Tandon N.N., Greco N.J., Ni Y., Wang T., Zhan X. Proteolysis of platelet cortactin by calpain. J Biol Chem 1997, 272:19248-19252.
63. Shin J.W., Swift J., Spinler K.R., Discher D.E. Myosin-II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes. Proc Natl Acad Sci US A 2011, 127:122-130.
64. Schwer H.D., Lecine P., Tiwari S., Italiano J.E., Hartwig J.H., Shivdasani R.A. A lineage-restricted and divergent beta-tubulin isoform is essential for the biogenesis, structure and function of blood platelets. Curr Biol 2001, 11:579-586.
65. Patel S.R., Richardson J.L., Schulze H., et al. Differential roles of microtubule assembly and sliding in proplatelet formation by megakaryocytes. Blood 2005, 106:4076-4085.